Brief Physical Activity Intervention for Older People With Multimorbidity
NCT ID: NCT05287932
Last Updated: 2022-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2022-05-09
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-organ Responses to CHronic Physical Activity and INactivity
NCT06377254
Active Body and Mind Intervention for Older Adults
NCT05233813
Optimizing Older Adults' Home Space for Physical Activity
NCT06407557
A Lifestyle Physical Activity Intervention for Older Sedentary Women
NCT01707693
Multicomponent Exercise Training in Frail Elderly
NCT03986840
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Brief physical activity intervention including an initial 45-minute physical activity consultation, telephone support after 2 weeks (approx. 15-minute call), and provision of a pedometer, written information, and a physical activity diary. Embedded behaviour change techniques will include goal setting, self-monitoring, building self-efficacy and social support, and overcoming barriers.
Brief physical activity intervention
See arm/group descriptions
Wait-list control
The control group will not receive any active or placebo intervention during the 4-week study period. They will also not receive any trial contacts during this period. They will however continue to be able to access their usual care from primary, secondary, community, and social services. After the final (4-week) follow-up assessment, this group will receive the full physical activity intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brief physical activity intervention
See arm/group descriptions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2 or more chronic conditions
* able to walk outside the home
* able to attend the study visits
Exclusion Criteria
* housebound
* ≥3 falls in previous year
* dementia or significant cognitive impairment (unable to follow simple instructions)
* contraindication to increasing physical activity
* unable to read or speak English
* unable to provide consent
* no more than one person per household
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northumbria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Garry Tew
Professor Garry Tew
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Garry A Tew, PhD
Role: PRINCIPAL_INVESTIGATOR
Northumbria University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northumbria University
Newcastle, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HLSGT030322
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.